Abstract
Novel 3,5-disubstituted 1,2,4-oxadiazoles 4a-4j were prepared from commercially available chlorosalicylaldehyde and screened for their cytotoxicity properties using brine shrimp (Artemia salina) bioassay and compared with the standard podophyllotoxin. The oxadiazoles 4a, 4c, 4e and 4h exhibited cytotoxicity activity in the series.
Keywords: 5-chlorosalicylaldehyde, Oxadiazoles, Cytotoxicity, Brine shrimp, Chromene derivatives, Synthesis, tyrosine kinase inhibitors, anti-inflammatory agents, Chromene derivatives, cytotoxicity properties
Letters in Drug Design & Discovery
Title:Synthesis and Cytotoxicity Evaluation of Some Novel 3,5-disubstituted- 1,2,4-Oxadiazoles
Volume: 9 Issue: 10
Author(s): M. Siva Nagi Reddy, B. Sailaja Kumari and B. Hari Babu
Affiliation:
Keywords: 5-chlorosalicylaldehyde, Oxadiazoles, Cytotoxicity, Brine shrimp, Chromene derivatives, Synthesis, tyrosine kinase inhibitors, anti-inflammatory agents, Chromene derivatives, cytotoxicity properties
Abstract: Novel 3,5-disubstituted 1,2,4-oxadiazoles 4a-4j were prepared from commercially available chlorosalicylaldehyde and screened for their cytotoxicity properties using brine shrimp (Artemia salina) bioassay and compared with the standard podophyllotoxin. The oxadiazoles 4a, 4c, 4e and 4h exhibited cytotoxicity activity in the series.
Export Options
About this article
Cite this article as:
Siva Nagi Reddy M., Sailaja Kumari B. and Hari Babu B., Synthesis and Cytotoxicity Evaluation of Some Novel 3,5-disubstituted- 1,2,4-Oxadiazoles, Letters in Drug Design & Discovery 2012; 9 (10) . https://dx.doi.org/10.2174/1570180811209050942
DOI https://dx.doi.org/10.2174/1570180811209050942 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers